Related Experiment Video
Updated: Dec 24, 2025
07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
16.3K
[Erdheim-Chester disease : a case report]
G Delporte1, I Delcorde2, A Rorive3
1Service d'Anatomie pathologique, CHU Liège, Belgique.
Revue Medicale De Liege
|April 9, 2020
Summary
Erdheim-Chester disease, a rare condition, was diagnosed in a woman with inflammatory symptoms. Targeted BRAF and MEK inhibitor therapies successfully improved her symptoms, highlighting a new treatment approach.
Area of Science:
- Oncology
- Hematology
- Radiology
Background:
- Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by systemic lipid-laden histiocyte infiltration.
- Clinical presentation can be diverse, often involving bone, cardiovascular, and central nervous systems, leading to diagnostic challenges.
Observation:
- A 47-year-old woman presented with unexplained inflammatory syndrome and asthenia.
- Imaging revealed bilateral abnormalities in the femurs and tibias, raising suspicion for Erdheim-Chester disease.
- Bone marrow biopsy confirmed the diagnosis of Erdheim-Chester disease.
Findings:
- Genetic analysis identified the BRAF V600E mutation in the affected bone marrow.
- The presence of the BRAF V600E mutation is a key molecular finding in a subset of Erdheim-Chester disease cases.
- This mutation is actionable with targeted therapies.
Implications:
- Targeted therapy with BRAF and MEK inhibitors resulted in significant clinical improvement of the patient's symptoms.
- This case underscores the importance of molecular profiling, specifically BRAF V600E mutation testing, in Erdheim-Chester disease.
- The findings support the use of targeted therapies as an effective treatment strategy for BRAF-mutated Erdheim-Chester disease, potentially improving patient outcomes.
Related Concept Videos
01:25Endocarditis II: Clinical Features of Infective Endocarditis
285
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
285
01:23Rheumatic Heart Disease I: Introduction
337
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
337
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
352
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
352